Drug Known as Proxalutamide Accelerates COVID-19 Viral Clearance While Reducing Time to Clinical Remission

Drug Known as Proxalutamide Accelerates COVID-19 Viral Clearance While Reducing Time to Clinical Remission

A joint American and Brazilian team recently studied a drug called proxalutamide as a treatment for COVID-19. A nonsteroidal antiandrogen (NSAA) under development, the hypothesis behind this trial was that TMPRSS2, regulated by the androgen receptor, hence SARS-CoV-2, infectivity is indirectly dependent on androgenic status and phenotype. Thus, a Phase 2 double blinded, randomized, placebo controlled prospective trial in mild to moderate COVID-19 patients. A non-hospitalized cohort but confirmed positive, key endpoints targeted included remission time (days) and the percentage of subjects confirmed negative on Day 7 after treatment. The study team concluded that this treatment serves to increase viral clearance of COVID-19 at Day 7 and reduce the average number of days to COVID-19 clinical transmission when compared to the placebo group.

Study Hypothesis

During the continuing SARS-CoV-2 (COVID-19) pandemic, the sponsors of this study revealed that a number of studies revealed a significant difference in the rate of severe cases between adult females and adult males (42% vs 58%).Among children under the age of 14, the rate of severe cases was reported to be low compared to al...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee